Home

CFAR

Personnel

Questions

Mission

Glossary

Clinical Trials

Feedback

CAB

Links

CLINICAL TRIALS:

Consents

CTU Newsletter 2/2009

Click trial to get more information

Longitudinal Study of Ocular Complications of AIDS :LSOCA

Immunogenicity & Safety of a Quadrivalent HPV Vaccine in HIV-1-Infected Females: A5240

The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen: A5241

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX in HIV-1-Infected Adults on Potent Combination ART with Conserved Immune Function: A5247

A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers: A5257

An Open Label Trial of Mecasermin For HIV Associated Metabolic Disease: Mecasermin

A Phase 1b Partially Randomized Pilot Study Intended to Evaluate the Safety and Immunological Effects of HIV-1DNA Immunization (PennVax-B) With or Without Co-administration of constructs Containing DNA Encoding For the Expression of Either IL-12 or IL-15 In HIV Infected Individuals: PennVax B

A Phase I Study of Autologous T-Cells Genetically Modified by Zinc Finger Nucleases SB-728 for Reduced CCR5 Expression in HIV-Infected Patients with Detectable Plasma HIV RNA who have Developed Resistance to Highly Active Anti-Retroviral Therapy (HAART):Sangamo

Pending Trials:

If you have any questions regarding these studies, Please call 215-349-8092

updated 2/10/09